-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Research Analysts Issue Forecasts for TRDA Q1 Earnings
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Entrada Therapeutics in a report issued on Thursday, February 27th. William Blair analyst M. Minter expects that the company will post earnings per share of ($0.73) for the quarter. The consensus estimate for Entrada […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Entrada Therapeutics in a report issued on Thursday, February 27th. William Blair analyst M. Minter expects that the company will post earnings per share of ($0.73) for the quarter. The consensus estimate for Entrada […]
